Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

41.7%

5 terminated/withdrawn out of 12 trials

Success Rate

58.3%

-28.2% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

143%

10 of 7 completed trials have results

Key Signals

10 with results

Enrollment Performance

Analytics

N/A
9(90.0%)
Phase 3
1(10.0%)
10Total
N/A(9)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

All 12 trials loaded